|
Market Closed -
Canadian Securities Exchange
09:30:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 0.005000 CAD | 0.00% |
|
0.00% | -66.67% |
| Market Cap | 671K 474K 417K 393K 359K 45.53M 676K 4.72M 1.83M 23.17M 1.78M 1.74M 75.41M | P/E 2024 |
-1.31x | P/E 2025 | -4.23x |
|---|---|---|---|---|---|
| Enterprise Value | 2.17M 1.54M 1.35M 1.27M 1.16M 147M 2.19M 15.28M 5.92M 75M 5.76M 5.64M 244M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
77.22% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| PHRX | Delayed | |
OTC Markets
| LMLLF | Delayed | |
|
Deutsche Boerse AG
| G11 | Delayed | |
|
Boerse Muenchen
| G11 | Real-time |
| 3 months | -50.00% | ||
| 6 months | -50.00% | ||
| Current year | -66.67% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.02 |
| 1 year | 0 | | 0.02 |
| 3 years | 0 | | 0.08 |
| 5 years | 0 | | 0.46 |
| 10 years | 0 | | 4.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kyle Appleby
DFI | Director of Finance/CFO | 50 | 2023-10-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul McClory
BRD | Director/Board Member | 82 | 2016-12-19 |
David Kideckel
CHM | Chairman | - | 2024-02-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/14/25 | Other | Chairman | 1,380,000 | 1.2929% | ||
| 5/3/24 | Other | Director | 0 | 0% | ||
| 5/3/24 | Option | Director | 500,000 | 0.5718% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -50.00% | -85.71% | 476K | |
| -1.27% | -1.16% | +14.30% | +98.19% | 103B | |
| +0.61% | -1.64% | +44.02% | +150.25% | 51.24B | |
| -0.39% | +0.59% | -14.50% | +266.43% | 20.74B | |
| -0.25% | -0.87% | -11.20% | -10.55% | 7.96B | |
| -1.66% | -0.34% | -38.67% | -34.93% | 6.92B | |
| -0.68% | +2.35% | -4.34% | +15.63% | 6.59B | |
| -1.27% | -2.00% | -19.87% | -33.84% | 5.99B | |
| +0.12% | -0.72% | -2.66% | +18.76% | 4.96B | |
| +1.06% | +8.52% | +20.18% | +22.51% | 3.76B | |
| Average | -0.40% | +0.30% | -6.27% | +40.67% | 21.08B | |
| Weighted average by Cap. | -0.63% | -0.69% | +14.14% | +109.36% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -793K -561K -493K -465K -424K -53.82M -799K -5.58M -2.16M -27.39M -2.11M -2.06M -89.14M | -383K -271K -238K -225K -205K -26.01M -386K -2.7M -1.04M -13.24M -1.02M -995K -43.08M |
| Net Debt | 1.27M 900K 792K 747K 681K 86.44M 1.28M 8.96M 3.47M 43.99M 3.38M 3.31M 143M | 1.5M 1.06M 933K 880K 803K 102M 1.51M 10.56M 4.09M 51.83M 3.98M 3.9M 169M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | $0.005000 | 0.00% | 1,400 |
| 26-09-21 | $0.005000 | 0.00% | 73,714 |
| 26-09-18 | $0.005000 | 0.00% | 7,000 |
| 26-09-17 | $0.005000 | 0.00% | 190,000 |
| 26-09-16 | $0.005000 | 0.00% | 38,000 |
- Stock Market
- Stocks
- PHRX Stock
Select your edition
All financial news and data tailored to specific country editions
